Posted by jrbecker76 on February 24, 2008, at 21:28:32
An interesting article in the New York Times about the industry's investment in the next class of glutamate modulators (mGlu prodrugs)....
http://www.nytimes.com/2008/02/24/business/24drug.html?_r=1&oref=slogin
for more information on these drugs in the pipleline see:
http://www.neurotransmitter.net/newdrugs.html
poster:jrbecker76
thread:814525
URL: http://www.dr-bob.org/babble/20080221/msgs/814525.html